Cancer is the name of a group of diseases characterized by the autonomous, uncontrolled growth and proliferation of cells in the body. The treatment of cancer is difficult and complicated. To date, available treatment strategies include surgery, chemotherapy, radiation therapy, and hormone therapy. The targeted antibody is a form of cancer therapy that can target multiple antigens, including soluble proteins, cancer cell surface antigens, and effector cell receptors, and has become a new option for cancer treatment.
Creative Biolabs provides a comprehensive range of primary antibodies for cancer microscopic research. These antibodies show high specificity, activity, performance and repeatability in a variety of technologies, including Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF) immunocytochemistry (ICC) and ELISA. These tools are commonly used to study apoptosis, cell growth, cell signaling, invasion / metastasis, oncoproteins, and metabolism.
High purity: SEC-HPLC analysis ensures the purity of each antibody product is ≥90% or ≥95%, depending on customer requirements.
High specificity: we conduct antigen binding tests to ensure antibodies with high affinity antigen specificity are obtained.
Protocols for antibody manipulation: The WB experiment guidelines covers all experimental conditions during a WB experiment. Products are strictly verified, and the data is accurate and reliable.
Comprehensive characterization: Multiple species and application quality testing to ensure that each antibody is a rigorously screened, high-quality product.
Explore our product range by research area below:
For more detailed information about our antibodies, please feel free to contact us.